Lexicon
-
The “Black Monday” for CNS drug-developing companies. Is the placebo “going wild and uncontrollable”?
To explore more efficient and stable clinical trial protocols, these “failures” are inevitably part of the cost
To explore more efficient and stable clinical trial protocols, these “failures” are inevitably part of the cost
